Vienna, Austria

Dirk B Strickmann

USPTO Granted Patents = 3 

Average Co-Inventor Count = 7.3

ph-index = 2

Forward Citations = 4(Granted Patents)


Location History:

  • Vienna, AT (2011 - 2012)
  • Purkersdorf, AT (2017)

Company Filing History:


Years Active: 2011-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Inventor Dirk B. Strickmann: Pioneering Innovation in Pharmaceuticals

Introduction

Dirk B. Strickmann, residing in Vienna, Austria, is a notable inventor with a keen focus on the development of innovative pharmaceutical compounds. With a total of three patents to his name, he stands out as a significant contributor to the field of microbiology and medicinal chemistry.

Latest Patents

Strickmann's latest patents include groundbreaking work on compounds known as 12-epi pleuromutilins. These compounds are derived from a complex structure characterized by significant variations in the mutilin ring. The first patent details a compound selected from various alkyl and aryl derivatives with unique substituents, including a methyl group with inverse stereochemistry compared to the naturally occurring pleuromutilin. The second patent focuses on pleuromutilin derivatives, emphasizing their use in treating diseases mediated by microbes. Such innovations showcase his dedication to advancing therapeutic options in pharmaceuticals.

Career Highlights

As an inventor at Nabriva Therapeutics AG, Dirk B. Strickmann has been at the forefront of developing new solutions to combat microbial infections. His work is not only instrumental in creating new pharmaceuticals but also plays a crucial role in addressing pressing medical challenges in the modern era.

Collaborations

Strickmann collaborates with esteemed colleagues such as Werner Heilmayer and Rosemarie Mang, contributing to an innovative and dynamic working environment that fosters the development of novel therapeutic compounds. Their combined expertise significantly enhances the potential for groundbreaking discoveries in treatment options.

Conclusion

Dirk B. Strickmann exemplifies the spirit of innovation in the pharmaceutical industry. With his impressive patent portfolio and collaborative efforts at Nabriva Therapeutics AG, he continues to push the boundaries of medical science, offering hope for effective treatments against microbial diseases. His dedication not only highlights his status as a distinguished inventor but also underscores the importance of innovation in enhancing global health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…